Skip to content

Adverse Drug Reaction

Classify an unintended, harmful response arising under correct drug use — not through any administration error — by an ABCDEF taxonomy whose pivotal dose-related-versus-idiosyncratic split reads off predictability, remedy, and whether trials could ever have caught it.

Core Idea

An adverse drug reaction (ADR) is an unintended harmful response in a patient receiving a drug at a normal dose — jointly requiring that the response is unintended, harmful, and occurs under correct use (correct drug, dose, indication, patient). That third condition separates ADRs from errors, overdose, or misuse. Its mechanism pairs the drug's intended action with an unintended one (off-target binding, reactive metabolite, immune sensitisation), underwriting the Edwards-Aronson ABCDEF taxonomy.

Scope of Application

Lives across clinical pharmacology and pharmacovigilance — one human-and-veterinary-pharmacology substrate-family.

  • Clinical pharmacology — forecasting Type A reactions from a drug's receptor-binding profile.
  • Pharmacovigilance and regulatory science — spontaneous-reporting systems (FAERS, VigiBase) for the Type B tail.
  • Hospital medication-safety programs — point-of-care decision support flagging interactions.
  • Pharmacoepidemiology — cohort analyses estimating incidence and susceptibility factors.
  • Vaccine, biologic, and device safety — the same surveillance apparatus on a shared substrate.

Clarity

Naming the ADR category draws the lines "side effects" erases: harm-under-correct-use versus harm-via-deviation (which forks the response), and adverse event versus ADR (correlation versus mechanism). The ABCDEF taxonomy converts "the drug did something bad" into mechanistically distinct types. The pivotal Type A versus B split tells the field something sharp about its evidence base — randomized trials can characterize A but are systematically blind to B, the gap pharmacovigilance fills.

Manages Complexity

The space of bad things on a drug is open-ended. The ADR category compresses it by reducing each event to a few discriminating parameters: the three-part definition sorts the causal track, a parallel cut separates adverse event from ADR, and the ABCDEF axis assigns a type carrying its consequences. From one question — dose-related and forecastable? — the analyst reads predictability, remedy, and expected evidence base. Time-and-use types (chronic, delayed, end-of-use, failure) extend the same logic.

Abstract Reasoning

A causal-track sort applies the three-part definition to route harm as intrinsic-to-drug or via-deviation, reaching for structured causality assessment (Naranjo, WHO-UMC). Type-assignment along ABCDEF reads off predictability, remedy, and — the sharpest inference — evidence-base visibility: Type B is systematically invisible to trials, so only surveillance can catch it. Remaining types extend one-feature-to-consequence along time and use. Boundary moves reject mis-modelled cases (not an error, not benign, not an externality).

Knowledge Transfer

Within clinical pharmacology the category transfers as mechanism — the ABCDEF taxonomy, causal-track sort, Type A-versus-B read, and causality assessment carry literally across drug classes (shared receptor templates) and product types (the surveillance apparatus ports to vaccines, biologics, devices on the shared post-marketing substrate). Beyond pharmacology the verdict is shared abstract mechanism with the ADR label not transferring: the intended-plus-unintended-harm skeleton recurs in software releases, policy, and security, but is owned by the parents side_effect, unintended_consequence, externality, risk, surveillance, and tail_risk. The ABCDEF, dose-response, and pharmacovigilance accent stays home. dag_edges:

Relationships to Other Abstractions

Local relationship map for Adverse Drug ReactionParents appear above the current abstraction, mutual partners to the right, and children below. Node labels state whether each abstraction is prime or domain-specific; colors identify relation types.Adverse Drug ReactionDOMAINDomain-specific abstraction: Pharmacological Interaction — is part of, conditionalPharmacologicalInteractionDOMAINPrime abstraction: Therapeutic Window — presupposes, conditionalTherapeuticWindowPRIMEDomain-specific abstraction: Adverse Drug Event — is a kind ofAdverseDrug EventDOMAINDomain-specific abstraction: Idiosyncratic Reaction — is a kind ofIdiosyncraticReactionDOMAIN

Current abstraction Adverse Drug Reaction Domain-specific

Parents (3) — more general patterns this builds on

  • Adverse Drug Reaction is a kind of Adverse Drug Event Domain-specific

    Every Adverse Drug Reaction is an Adverse Drug Event specialized by the correct-use precondition and the ABCDEF mechanism-and-time taxonomy.

  • Adverse Drug Reaction is part of, conditional Pharmacological Interaction Domain-specific

    Pharmacological Interaction is a constitutive part of Adverse Drug Reaction.

  • Adverse Drug Reaction presupposes, conditional Therapeutic Window Prime

    The window-governed Type-A branch of Adverse Drug Reaction conditionally presupposes a Therapeutic Window whose upper harm margin ordinary dose-responsive pharmacology approaches or crosses.

Children (1) — more specific cases that build on this

  • Idiosyncratic Reaction Domain-specific is a kind of Adverse Drug Reaction

    Idiosyncratic Reaction is the Type-B Adverse Drug Reaction specialized by dose independence, qualitative novelty, and a rare susceptible subgroup.

Hierarchy paths (7) — routes to 6 parentless roots

Neighborhood in Abstraction Space

Adverse Drug Reaction sits in a moderately populated region (41st percentile for distinctiveness): it has near-neighbors but no dense thicket of look-alikes.

Family — Pharmacokinetics & Drug Response (19 abstractions)

Nearest neighbors

Computed from structural-signature embeddings · 2026-07-12